NEWS DETAIL

美國FDA批准INQOVI®合併維奈托克(Venetoclax)上市,這是第一個用於治療不適合接受強化誘導化療的急性髓性白血病患者的全口服聯合療法—商業資訊

美國FDA核准INQOVI®合併維奈托克(Venetoclax)上市,是第一個用於治療不適合接受強化誘導化療的急性骨髓性白血病患者的全口服合併療法。

醫藥資訊

该文章暂未提取到完整正文,已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

Products Mentioned in This Article

These products were automatically matched from the article title, summary, and full content.

Frequently Asked Questions

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Venetoclax – Buy online、VECLADX Venetoclax 100mg、Lucius Quizartinib – Buy Online、Lucius Anagrelide – Buy Online.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat